This research-focused Master's program trains students in both fundamental neuroscience research and clinically oriented, therapeutic approaches. It aims to deepen understanding of the cellular and molecular processes that underlie nervous system function and dysfunction, with the ultimate goal of improving diagnosis and treatment for neurological and psychiatric conditions. The programme highlights disorders such as multiple sclerosis, stroke, depression, schizophrenia, traumatic brain injury, ALS, dementia and Parkinson’s disease — conditions that can severely reduce quality of life and independence.
The curriculum emphasizes investigation of physiological and pathophysiological mechanisms that govern neural adaptation and homeostasis, serving as a bridge between cellular and pharmacological laboratory studies, molecular neurobiology, behavioural physiology, diagnostics and pharmacological applications. Knowledge gained in the programme is explicitly intended to be translated into targeted strategies for innovative therapies and preventive measures, addressing the gaps in efficacy seen with many current treatments.
Taught in English, the programme provides theoretical, methodological and practical training in the cellular and molecular processes leading to neural disease and in the application of this knowledge to new diagnostic or therapeutic procedures and clinical contexts. A close collaboration with the pharmaceutical company Boehringer Ingelheim gives students additional exposure to how research findings can be developed and applied within industry settings.
Key facts / entry expectations (confirm exact requirements on the official programme page)
Overview
This two-year, four-semester Master's programme is taught entirely in English and takes an interdisciplinary approach to molecular and translational neuroscience. Teaching and assessment are delivered by faculty from the Department of Neurology, the Institutes of Medicine, Biology and Biochemistry at Ulm University, Ulm University Hospital, and specialists from the CNS department of Boehringer Ingelheim. The curriculum emphasizes the connection between fundamental neuroscience research and the development of new therapeutics, giving students a strong orientation toward translational applications.
Core content and electives
In the first semester you complete compulsory modules that build foundational knowledge in neuroanatomy, neurophysiology and molecular and translational neuroscience, together with a mandatory practical laboratory methods course. A broad selection of elective modules allows you to shape your own profile — options span topics such as stem cell biology, ageing research, stress physiology, brain imaging techniques, European patent law and medical statistics, among others. These electives enable targeted specialization depending on your career goals in research, industry or clinical settings.
Practical training, research and outcomes
The programme integrates hands-on practical experience: in the third semester students undertake several-week internships in modern research laboratories at Ulm University, Ulm University Hospital or at external partner sites. The fourth semester is dedicated to the independent Master's thesis. Graduates leave the programme with a strong understanding of brain structure and function, molecular mechanisms underlying neurological disease, practical laboratory skills, and the ability to translate basic research findings toward therapeutic development and further research careers.
Program requirements (key points)
Applicants must have a completed Bachelor’s degree in biology or a closely related life-sciences subject, or hold an equivalent qualification. Acceptable fields include biology, biochemistry, molecular medicine, physiological chemistry, neurobiology, biopsychology, human biology, molecular life science, or other programmes that cover essentially the same content.
Degrees may come from higher education institutions in Germany or abroad. Equivalent qualifications are considered provided they represent at least three years of university-level study.
“Good examination results” are demonstrated by a final Bachelor’s grade of 2.7 or better. If your Bachelor’s degree has not yet been awarded at the time of application, you must submit all completed examination results up to the application date showing an average grade of 2.7 or better. These results must be documented in a current transcript of records.
Admission requirements (bulleted)
Practical tip: make sure your transcripts clearly show grades and how averages were calculated; if documents are not in German or English, provide certified translations where required.
Winter Semester (International)
15 May 2026
Winter Semester (EU/EEA)
15 May 2026
Graduates are prepared for research careers in academia, clinical research settings and the pharmaceutical/biotech industry, working as research scientists, translational neuroscientists, or in roles supporting drug discovery, diagnostics development and preclinical/clinical studies. The programme's practical lab training and industry collaboration make graduates attractive for R&D positions in companies and research institutes.
The programme also provides a solid foundation for doctoral studies (combined Master’s–PhD pathways are available), as well as for careers in regulatory affairs, clinical trial management, or scientific consultancy where molecular neuroscience expertise is required.